$78.650
-2.415 (-3.07%)Zum Schluss
CCI-News
CCI-Events
Crown Castle Raises FY26 Adjusted EBITDA Outlook to $2.72B
Raises FY26 adjusted EBITDA view to $2.72B from $2.69B. "We are increasing our full year 2026 guide for Adjusted EBITDA by $25 million and AFFO by $5 million to reflect higher ground lease buyout activity, additional operational efficiencies, and the impact of a customer agreement," said Sunit Patel, Crown Castle's CFO. "In the quarter we acquired an outstanding residual economic interest on a subset of our tower sites and extended the term of a significant customer on those sites. We ended the third quarter with a strong balance sheet, including 97% fixed rate debt, a weighted average debt maturity of approximately 7 years, and approximately $3.9 billion of availability under our revolving credit facility."
Crown Castle Reports Q3 Revenue of $995M
Reports Q3 revenue $995M, consensus $1.01B. "In the third quarter, we improved margins and strengthened our customer relationships including the completion of an agreement with a key customer," said Chris Hillabrant, Crown Castle's president and CEO. "As we look ahead, we remain focused on becoming a best-in-class U.S. tower operator by driving additional operating efficiencies, modernizing our systems, and increasing our land ownership under our towers. We believe our pure-play U.S. tower strategy, disciplined capital allocation framework, and investment-grade balance sheet position us to deliver attractive long-term shareholder returns."
Crown Castle Stock Rises 14.1% to $78.63
Crown Castle is up 14.1%, or $9.74 to $78.63.
Crown Castle Stock Rises 10.7% to $76.30
Crown Castle is up 10.7%, or $7.41 to $76.30.
Humana and Others See Notable Gains in Options Trading
Notable gainers among liquid option names this morning include Humana (HUM) $443.94 +56.82, Crown Castle (CCI) $76.25 +7.36, SBA Communications (SBAC) $181.30 +11.29, American Tower (AMT) $177.69 +10.97, and Moderna (MRNA) $205.38 +8.38.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.









